Insights

Innovative Protein Screening Nuclera's cutting-edge multiplex protein screening technology, eProtein Discovery™, enables rapid in-house production and characterization of challenging proteins, making it highly appealing to research labs aiming to accelerate drug discovery and protein analysis processes.

Strategic Collaborations The company's recent partnerships with AI and biophysical technology providers like leadXpro AG and Cytiva suggest opportunities for joint integrated solutions, appealing to organizations seeking advanced, end-to-end, automation-enabled workflows for protein research.

Growing Market Presence Recognition in rankings like the Sifted 100 and recent awards indicate strong industry visibility, which could attract clients in the biotech and pharmaceutical sectors looking for reputable suppliers of innovative protein science tools.

Recent Funding Boost With a substantial Series C funding round totaling $87 million, Nuclera is well-positioned to expand its product offerings and market reach, providing an opportunity for sales teams to target expanding labs and institutions modernizing their protein research capabilities.

Industry Expansion Opportunities Nuclera's recent product launch of gpcr-focused nanodisc panels and collaborations with research institutions highlight potential sales prospects among organizations interested in membrane protein research and advanced biophysical analysis solutions.

Nuclera Tech Stack

Nuclera uses 8 technology products and services including Oracle Database, MySQL, Microsoft Excel, and more. Explore Nuclera's tech stack below.

  • Oracle Database
    Database
  • MySQL
    Database
  • Microsoft Excel
    Editors
  • Mailjet
    Email
  • Modernizr
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • PyScript
    Miscellaneous
  • Nginx
    Web Servers

Media & News

Nuclera's Email Address Formats

Nuclera uses at least 1 format(s):
Nuclera Email FormatsExamplePercentage
FLast@nuclera.comJDoe@nuclera.com
98%
FMiddleLast@nuclera.comJMichaelDoe@nuclera.com
1%
Last@nuclera.comDoe@nuclera.com
1%

Frequently Asked Questions

Where is Nuclera's headquarters located?

Minus sign iconPlus sign icon
Nuclera's main headquarters is located at Chivers Way Cambridge, England United Kingdom. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Nuclera's official website and social media links?

Minus sign iconPlus sign icon
Nuclera's official website is nuclera.com and has social profiles on LinkedInCrunchbase.

What is Nuclera's SIC code NAICS code?

Minus sign iconPlus sign icon
Nuclera's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nuclera have currently?

Minus sign iconPlus sign icon
As of June 2026, Nuclera has approximately 130 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Commercial Officer (cco): J. B.Chief Financial Officer: S. B.Chief Information Security Officer: A. Z.. Explore Nuclera's employee directory with LeadIQ.

What industry does Nuclera belong to?

Minus sign iconPlus sign icon
Nuclera operates in the Biotechnology Research industry.

What technology does Nuclera use?

Minus sign iconPlus sign icon
Nuclera's tech stack includes Oracle DatabaseMySQLMicrosoft ExcelMailjetModernizrMicrosoftPyScriptNginx.

What is Nuclera's email format?

Minus sign iconPlus sign icon
Nuclera's email format typically follows the pattern of FLast@nuclera.com. Find more Nuclera email formats with LeadIQ.

When was Nuclera founded?

Minus sign iconPlus sign icon
Nuclera was founded in 2013.

Nuclera

Biotechnology ResearchEngland, United Kingdom51-200 Employees

Nuclera exists to remove uncertainty from protein science. As the pioneer of multiplex protein screening, we help researchers start with clarity, so ideas move faster to result. We believe access to your protein should be a certainty, not a gamble. eProtein Discovery™ is how we deliver on that promise, but our aim is bigger: to make protein access routine for every lab, accelerate breakthroughs in human health, and empower scientists to spend more time on discovery and less on delay.

Our eProtein Discovery™ system combines unique cell free expression systems, novel digital microfluidics, and robust screening data, to create an effortlessly multiplex protein screening solution that empowers you to perform your own protein screening, characterization, and small-scale expression in-house within days — even challenging membrane proteins

Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.

Section iconCompany Overview

Headquarters
Chivers Way Cambridge, England United Kingdom
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $10M$25M

    Nuclera's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Nuclera's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.